Adaptin Bio, Inc. (APTN)

Adaptin Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Debt / Equity Ratio	-0.14	-	-0.30	-0.48	-
Net Debt / Equity Ratio	0.03	0.31	-0.30	-0.48	0.01
Quick Ratio	0.12	0.22	0.01	0.01	0.01
Current Ratio	0.28	0.29	0.01	0.01	0.01
Return on Assets (ROA)	-200.44%	-788.36%	-1315.63%	-22827.77%	-
Return on Capital Employed (ROCE)	321.50%	363.60%	62.70%	89.70%	124.50%
Buyback Yield / Dilution	-119.06%	-140.38%	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 10, 2026

Data Sources Report a data error